Europe In-vitro Diagnostics Market

Europe In-vitro Diagnostics Market Size, Share, Growth Analysis, By Product Type(Instruments, Reagents & Consumables), By Technique(Immunodiagnostics, Clinical Chemistry), By Setting(Laboratories, Point of Care), By Application(Infectious Diseases, Cardiology), By End-user(Clinical Laboratories, Hospitals), By Country/ Sub-Region(Germany, U.K.) - Industry Forecast 2024-2031


Report ID: UCMIR35G2186 | Region: Regional | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Europe In-vitro Diagnostics Market Insights

Market Overview:

The European region ranks as the second-largest contributor to the worldwide in-vitro diagnostics market. Forecasts anticipate a consistent growth trajectory with a projected Compound Annual Growth Rate (CAGR) of 7.1% for the European in-vitro diagnostics market. The global in-vitro diagnostics market is expected to surge from USD 94.67 billion in 2022 to USD 157.02 billion by 2030.

Europe In-vitro Diagnostics Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Technology by segment aggregation, the contribution of the Health Care Technology in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Europe In-vitro Diagnostics was estimated to be valued at US$ XX Mn in 2021.

The Europe In-vitro Diagnostics Market is estimated to grow at a CAGR of XX% by 2028.

The Europe In-vitro Diagnostics Market is segmented on the basis of Product Type, Technique, Setting, Application, End-user, Country/ Sub-Region.

Based on region, the Europe In-vitro Diagnostics Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Europe In-vitro Diagnostics Market are , bioMérieux SA , Qiagen N.V. , F. Hoffmann-La Roche Ltd , Siemens Healthineers AG , DiaSorin S.p.A. , Danaher Corporation , Bio-Rad Laboratories , Abbott , Becton Dickinson and Company , Quidel Corporation .

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Europe In-vitro Diagnostics Market

Product ID: UCMIR35G2186

$5,300
BUY NOW GET FREE SAMPLE